An established chemoradiation regimen is compared with gemcitabine and once-daily radiation in the selective bladder-sparing treatment of muscle-invasive bladder cancer.
from Latest articles from Cancer Therapy Advisor News https://ift.tt/2A2aqbp
from Latest articles from Cancer Therapy Advisor News https://ift.tt/2A2aqbp